Full Year 2022 Santhera Pharmaceuticals Holding AG Earnings Call Transcript
Ladies and gentlemen, welcome to the Santhera Pharmaceuticals 2022 financial results and corporate update conference call. I am Sandra, the Chorus Call operator. I would like to remind you that all participants will be in listen-only mode, and the conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions)
This conference call may contain certain forward-looking statements based on the current assumptions and forecasts made by Santhera Pharmaceuticals. Such statements involve certain risks, uncertainties, and other factors, which could cause the actual results, financial condition, performance, and achievement of Santhera Pharmaceuticals to be materially different from those expressed or implied by such statements.
These factors include those discussed and the comprehensive risk factor disclosure of the company's website at www.santhera.com. Santhera disclaims any obligation to update any forward-looking statements. The conference may be downloaded on Santhera's website
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |